咨询电话：15012456311
咨询电话：15012456311英国NIBSC标准品WHO标准品是深圳远扬化学技术有限公司的热销产品，主要应用在哪些领域呢？
英国国家生物制品检定所是WHO的一个标准品供应中心实验室，它的核心工作是制备、保存和分发WHO用于检测生物制品质量的标准品。NIBSC制备的流感毒株和检测抗原、抗血清标准品，保障了各厂家顺利的研究和生产。NIBSC提供对投入英国市场的生物药品的独立测试，尤其是用于英国儿童免疫计划的疫苗；它同时也是欧盟控制药品进入欧盟市场的药品控制实验室(OMCL)。 如果出现不能满足药品存放要求或患者出现不良反应等问题，NIBSC 也可对已投入欧盟市场的产品进行检验。
NIBSC 战略目标：对有关生物产品的问题给出回复和建议；提供生物药品方面的国家科技力量，维持满足科学和药物学领域新发展需求的灵活性、专业知识和设施；
作为化验方法（如量化生物学活性以及确定生物产品特征和进行安全评估）方面的机构运营并得到认同；
在欧洲生物产品的控制和标准化方面，继续发挥科学基础开发的中心作用；
在生物药品法规的科学方面帮助社会达成共识，并籍于此，与世界卫生组织紧密合作；
在控制和标准化的关键领域实现和维护质量鉴定。
生物药品控制
药品中使用的生物物质包括病毒和细菌疫苗、从人类血液提取的产物、荷尔蒙以及其它诸如细胞分裂素和生长素等治疗药物。
这些生物物质对药物学和公众健康做出了巨大贡献并发挥着越来越大的作用，它们大大改善了*的疾病预防、诊断和治疗。
深圳远扬化学技术有限公司所售英国NIBSC标准品部分产品列表：
（篇幅有限，更多产品，欢迎进入我司展台查询）
| 07/288 | BCG Vaccine of Russian BCG-I sub-strain(15st WHO Reference Reagent) |
| 01/535 | Meningococcal serogroup W polysaccharide |
| 07/352 | BCG Vaccine of Russian BCG-I sub-strain(79st WHO Reference Reagent) |
| 07/281 | BCG Vaccine of Russian BCG-I sub-strain(8st WHO Reference Reagent) |
| 10/164 | Reteplase Reference Material |
| 95/571 | Interleukin-32 (Human, rDNA derived) |
| 13/219 | Influenza Antigen B/Massachusetts/02/2097 (Egg derived) |
| 10/149 | Reteplase Reference Material |
| 07/344 | BCG Vaccine of Russian BCG-I sub-strain(71st WHO Reference Reagent) |
| 01/484 | Meningococcal serogroup W polysaccharide |
| 13/154 | Influenza Antigen B/Massachusetts/02/2032 (Egg derived) |
| 13/151 | Influenza Antigen B/Massachusetts/02/2029 (Egg derived) |
| 10/143 | Reteplase Reference Material |
| 01/476 | Meningococcal serogroup W polysaccharide |
| 12/B623-057 | QCRFLUAH1N1QC1-Influenza AH1N1 QC55 |
| 12/B623-053 | QCRFLUAH1N1QC1-Influenza AH1N1 QC51 |
| 12/B623-051 | QCRFLUAH1N1QC1-Influenza AH1N1 QC49 |
| 13/275 | Polio Anti Sabin type 58 (inactivated) Serum |
| 12/B623-003 | QCRFLUAH1N1QC1-Influenza AH1N1 QC1 |
| 07/315 | BCG Vaccine of Russian BCG-I sub-strain(42st WHO Reference Reagent) |
| 13/285 | Polio Anti Sabin type 68 (inactivated) Serum |
| 03/104-019 | HTLV-4 (antibody) Monitor Sample |
| 13/153 | Influenza Antigen B/Massachusetts/02/2031 (Egg derived) |
| 12/B623-097 | QCRFLUAH1N1QC1-Influenza AH1N1 QC95 |
| 10/144 | Reteplase Reference Material |
| 95/657 | Interleukin-118 (Human, rDNA derived) |
| 13/219 | Polio Anti Sabin type 2 (inactivated) Serum |
| 03/104-085 | HTLV-70 (antibody) Monitor Sample |
| 01/472 | Meningococcal serogroup W polysaccharide |
| 13/146 | Influenza Antigen B/Massachusetts/02/2024 (Egg derived) |
| 07/329 | BCG Vaccine of Russian BCG-I sub-strain(56st WHO Reference Reagent) |
| 13/165 | Influenza Antigen B/Massachusetts/02/2043 (Egg derived) |
| 13/281 | Polio Anti Sabin type 64 (inactivated) Serum |
| 07/306 | BCG Vaccine of Russian BCG-I sub-strain(33st WHO Reference Reagent) |
| 03/104-110 | HTLV-95 (antibody) Monitor Sample |
| 07/358 | BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent) |
| 01/452 | Meningococcal serogroup W polysaccharide |
| 13/277 | Polio Anti Sabin type 60 (inactivated) Serum |
| 07/287 | BCG Vaccine of Russian BCG-I sub-strain(14st WHO Reference Reagent) |
| 13/287 | Polio Anti Sabin type 70 (inactivated) Serum |
| 13/307 | Polio Anti Sabin type 90 (inactivated) Serum |
| 10/186 | Reteplase Reference Material |
| 10/133 | Reteplase Reference Material |
| 03/104-094 | HTLV-79 (antibody) Monitor Sample |
| 12/B623-031 | QCRFLUAH1N1QC1-Influenza AH1N1 QC29 |
| 07/377 | BCG Vaccine of Russian BCG-I sub-strain(104st WHO Reference Reagent) |
| 13/269 | Polio Anti Sabin type 52 (inactivated) Serum |
| 10/179 | Reteplase Reference Material |
| 10/210 | Reteplase Reference Material |
| 13/266 | Polio Anti Sabin type 49 (inactivated) Serum |
| 07/295 | BCG Vaccine of Russian BCG-I sub-strain(22st WHO Reference Reagent) |
| 07/371 | BCG Vaccine of Russian BCG-I sub-strain(98st WHO Reference Reagent) |
| 12/B623-078 | QCRFLUAH1N1QC1-Influenza AH1N1 QC76 |
| 01/462 | Meningococcal serogroup W polysaccharide |
| 95/591 | Interleukin-52 (Human, rDNA derived) |
| 01/464 | Meningococcal serogroup W polysaccharide |
| 10/159 | Reteplase Reference Material |
| 03/104-046 | HTLV-31 (antibody) Monitor Sample |
| 13/213 | C-Peptide, Human. 68st International Standard. |
| 13/222 | Influenza Antigen B/Massachusetts/02/2100 (Egg derived) |
| 07/373 | BCG Vaccine of Russian BCG-I sub-strain(100st WHO Reference Reagent) |
| 12/B623-110 | QCRFLUAH1N1QC1-Influenza AH1N1 QC108 |
| 13/196 | C-Peptide, Human. 51st International Standard. |
| 12/B623-043 | QCRFLUAH1N1QC1-Influenza AH1N1 QC41 |
| 01/494 | Meningococcal serogroup W polysaccharide |
| 13/192 | Influenza Antigen B/Massachusetts/02/2070 (Egg derived) |
| 07/325 | BCG Vaccine of Russian BCG-I sub-strain(52st WHO Reference Reagent) |
| 07/348 | BCG Vaccine of Russian BCG-I sub-strain(75st WHO Reference Reagent) |
| 13/223 | Influenza Antigen B/Massachusetts/02/2101 (Egg derived) |
| 12/B623-086 | QCRFLUAH1N1QC1-Influenza AH1N1 QC84 |
| 13/191 | Influenza Antigen B/Massachusetts/02/2069 (Egg derived) |
| 01/488 | Meningococcal serogroup W polysaccharide |
| 07/343 | BCG Vaccine of Russian BCG-I sub-strain(70st WHO Reference Reagent) |
| 12/B623-019 | QCRFLUAH1N1QC1-Influenza AH1N1 QC17 |
| 10/125 | Reteplase Reference Material |
| 10/155 | Reteplase Reference Material |
| 13/185 | Influenza Antigen B/Massachusetts/02/2063 (Egg derived) |
| 13/243 | C-Peptide, Human. 98st International Standard. |
| 13/137 | Influenza Antigen B/Massachusetts/02/2015 (Egg derived) |
| 13/201 | C-Peptide, Human. 56st International Standard. |
| 07/311 | BCG Vaccine of Russian BCG-I sub-strain(38st WHO Reference Reagent) |
| 13/242 | C-Peptide, Human. 97st International Standard. |
| 13/175 | C-Peptide, Human. 30st International Standard. |
| 13/201 | Influenza Antigen B/Massachusetts/02/2079 (Egg derived) |
| 03/104-041 | HTLV-26 (antibody) Monitor Sample |
| 03/104-074 | HTLV-59 (antibody) Monitor Sample |
| 95/646 | Interleukin-107 (Human, rDNA derived) |
| 13/156 | C-Peptide, Human. 11st International Standard. |
| 01/465 | Meningococcal serogroup W polysaccharide |
| 03/104-050 | HTLV-35 (antibody) Monitor Sample |
| 10/121 | Reteplase Reference Material |
| 13/235 | Influenza Antigen B/Massachusetts/02/2113 (Egg derived) |
| 01/519 | Meningococcal serogroup W polysaccharide |
| 07/364 | BCG Vaccine of Russian BCG-I sub-strain(91st WHO Reference Reagent) |
| 95/566 | Interleukin-27 (Human, rDNA derived) |
| 13/204 | C-Peptide, Human. 59st International Standard. |
| 13/205 | Influenza Antigen B/Massachusetts/02/2083 (Egg derived) |
| 13/241 | C-Peptide, Human. 96st International Standard. |
| 07/324 | BCG Vaccine of Russian BCG-I sub-strain(51st WHO Reference Reagent) |
| 95/626 | Interleukin-87 (Human, rDNA derived) |
